NDC 66758-142-58 - Exelon
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66758-142
- Requested NDC
- 66758-142-58
- Package NDCs from labels
- 66758-142-58, 66758-142-31
- Manufacturer
- Sandoz Inc
- Effective date
- 2024-05-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Exelon - Sandoz Inc | Sandoz Inc | 2024-05-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66758-142-31 | Exelon | 30 in 1 CARTON | PATCH, EXTENDED RELEASE | 30 | 1 | |
| 66758-142-58 | Exelon | 24 h in 1 PATCH | PATCH, EXTENDED RELEASE | 24 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66758-142-31 | EA - Each | 66758-142 | 4b587db6-52f4-4f2c-8d4a-1c55d84b8e90 | 1 | 2025-11-13 |
| 66758-142-58 | EA - Each | 66758-142 | 4c513647-dc0c-4114-889e-820cf822e374 | 1 | 2025-11-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | 1ebeb8ec-5348-4bb1-ab3d-834690351094 | 2024-12-24 | Warnings, Adverse reactions | 725023 PKI06M3IW0 |
| Rivastigmine | RIVASTIGMINE | Mylan Pharmaceuticals Inc. | 4ab335d1-19ee-4cd9-9776-8086645d19e4 | 2024-09-21 | Warnings, Adverse reactions | 725021 1308569 725023 PKI06M3IW0 |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | 82630f84-fb47-47ab-8ee2-1720a486de02 | 2024-08-19 | Warnings, Adverse reactions | 725021 PKI06M3IW0 |
| Rivastigmine | RIVASTIGMINE | Amneal Pharmaceuticals LLC | 8b671fc9-8cb0-4406-a9ee-7c95086d6200 | 2024-07-02 | Warnings, Adverse reactions | 725021 1308569 725023 PKI06M3IW0 |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | c569f760-f311-42ba-909c-a36319622b35 | 2024-05-30 | Warnings, Adverse reactions | 725023 PKI06M3IW0 |
| Rivastigmine | RIVASTIGMINE | Zydus Pharmaceuticals USA Inc. | 64dad603-2389-456b-8c18-d1d40b7e7419 | 2024-05-27 | Warnings, Adverse reactions | 725021 1308569 725023 PKI06M3IW0 |
| Rivastigmine | RIVASTIGMINE | Sandoz Inc | 92a58ebb-748d-49f4-bf11-ecbcf5424152 | 2024-05-08 | Warnings, Adverse reactions | NDA022083 725021 1308569 725023 PKI06M3IW0 |
| Exelon | RIVASTIGMINE | Novartis Pharmaceuticals Corporation | 07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0 | 2024-05-08 | Warnings, Adverse reactions | NDA022083 725021 1308571 751302 725105 1308569 725023 PKI06M3IW0 |
| Exelon | RIVASTIGMINE | Sandoz Inc | b6ed6d15-116d-4596-92ce-3414574d7ba0 | 2024-05-08 | Warnings, Adverse reactions | NDA022083 66758-142-31 66758-143-31 66758-144-31 66758-143-58 66758-144-58 66758-142-58 66758-143 66758-142 66758-144 66758014258 725021 1308571 751302 725105 1308569 725023 b6ed6d15-116d-4596-92ce-3414574d7ba0 b6ed6d15-116d-4596-92ce-3414574d7ba0 PKI06M3IW0 |
| Floriva | VITAMIN A ACETATE, .BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, LEVOMEFOLATE GLUCOSAMINE, FOLIC ACID, CYANOCOBALAMIN, BIOTIN, ZINC GLUCONATE, CUPRIC OXIDE, AND SODIUM FLUORIDE | BonGeo Pharmaceuticals, Inc. | 34b2924f-d220-4344-8cdd-e7dda54061c2 | 2024-02-02 | Warnings | H4N855PNZ1 |
| Floriva | VITAMIN A ACETATE, .BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, LEVOMEFOLATE GLUCOSAMINE, FOLIC ACID, CYANOCOBALAMIN, BIOTIN, ZINC GLUCONATE, CUPRIC OXIDE, AND SODIUM FLUORIDE | BonGeo Pharmaceuticals, Inc. | 768502e2-541f-4de8-ac68-3ab47c1f436d | 2024-02-01 | Warnings | H4N855PNZ1 |
| Floriva | VITAMIN A ACETATE, .BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, LEVOMEFOLATE GLUCOSAMINE, FOLIC ACID, CYANOCOBALAMIN, BIOTIN, ZINC GLUCONATE, CUPRIC OXIDE, AND SODIUM FLUORIDE | BonGeo Pharmaceuticals, Inc. | 3d5fbe3a-a95b-4688-a96e-b34e6e1e868a | 2024-02-01 | Warnings | H4N855PNZ1 |
| Pain Formula | SALIX ALBA, ASCORBICUM ACIDUM, VITAMIN A, VITAMIN E, ACETYLSALICYLICUM ACIDUM | Nutritional Specialties, Inc. | 0cc0d205-83c2-4205-a93c-6a8ba55956d4 | 2023-11-20 | Warnings | H4N855PNZ1 |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | H4N855PNZ1 |
| Telomere - DNA | CA98, CAROTENOID, DNA, GLUTATHIONE, OMEGA 3, PITUITARUM, RNA, VITAMIN B COMPLEX, VITAMIN C, VITAMIN D3, VITAMIN E | ProBLEN | b093dfba-ed48-47a2-b4ce-f706221935a1 | 2022-11-30 | Warnings | H4N855PNZ1 |
| Immune Support | ARSENICUM ALBUM, RUMEX, SQUILLA MARITIMA, BRYONIA ALBA, KALI CARBONICUM, GLUTATHIONE, VITAMIN C, VITAMIN C, ZINC PICOLINATE, VITAMIN B, VITAMIN E, BETA GLUCAN, CURCUMIN, GRAPEFRUIT SEED, OREGANO LEAF, GARLIC BULB, OLIVE LEAF, APPLE CIDER VINEGAR, ASTRAGALUS ROOT, MAITAKE MUSHROOM, CATS CLAW BARK | ProBLEN | e6f26cf4-dc3d-4d31-aa3e-145167b6ba2b | 2022-11-30 | Warnings | H4N855PNZ1 |
| ANTI AGE SKIN | ALPHA-TOCOPHEROL - ASCOPHYLLUM NODOSUM - BOTRYOGLOSSUM PLATYCARPUM - FUCUS SERRATUS - FUCUS VESICULOSUS - ISOLEUCINE - LEUCINE - RETINOL - SELENIUM - SUS SCROFA CAPILLARY TISSUE - SUS SCROFA COLLAGEN - SUS SCROFA PLACENTA - SUS SCROFA SKIN - UBIDECARENONE - ULVA LACTUCA EXTRACT - LAMINARIA DIGITATA | Guna spa | f0c53be7-01ac-40ed-b3cd-8911ba704346 | 2018-12-21 | Warnings | H4N855PNZ1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.